This article will walk through what peptides are, how they developed historically, how they are used today, where your clinics peptide packages fit in, how they compare to hormone therapies like testosterone replacement therapy (TRT), and why lifestyle (training, movement, nutrition, sleep) is still the foundation
Indications: Oral Drugs and injections, for the therapy of drug intoxication, metal intoxication, liver function disorders in chronic liver diseases, corneal injury, leucopeniaby radiotherapy
resM GLP-1 Postbiotic Resbiotic Nutrition Already have an account
Italy Spain Rest of Europe Asia Pacific China Japan India South Korea South-east Asia Rest of Asia Pacific Latin America Brazil Argentina Rest of Latin America Middle East & Africa GCC Countries South Africa Rest of the Middle East and Africa Regional Analysis: North America The North America GLP-1 Receptor Agonist Market size was valued at USD 11,474.32 million in 2018 to USD 21,092.81 million in 2024 and is anticipated to reach USD 81,088.80 million by 2032, at a CAGR of 18.4% during the forecast period
Heres a closer look at the four major GLP-1 drugs on the market (Ozempic, Mounjaro, Wegovy, and Zepbound): Of these medications, only Zepbound (known generically as tirzepatide) is FDA-approved to treat sleep apnea in those with a body mass index (BMI) of 30 or higher
We accept HSA and FSA cards
